Category: Rejuvenation

Rejuvenation

Latest

New Data Confirms Long-Term Safety of RelabotulinumtoxinA

Baldo Scassellati Sforzolini, MD, PhD, MBA, Galderma’s global head of research, recently presented data on RelabotulinumtoxinA, a six-month neuromodulator for wrinkles. The READY-4 trial confirms its safety and efficacy, supported by PEARL Technology across diverse groups. Here, Sforzolini shares his findings.